Converge Bio
Accelerating therapeutic breakthroughs with AI
About Converge Bio
Converge Bio is at the forefront of integrating Generative AI with biological data. Our mission is to empower biotech and pharmaceutical companies to discover and develop more effective drugs faster, utilizing the power of Large Language Models (LLMs) specifically trained on biological languages.
Converge Bio website preview
Company facts
- Category
- SaaS
- Funding stage
- Series A
- Total raised
- $0
- Founded
- 2020
- Team size
- 11–50
- HQ
- Tel Aviv, Israel
- Country
- Israel
- Website
- converge-bio.com
Frequently asked questions
What does Converge Bio do?
Converge Bio is at the forefront of integrating Generative AI with biological data. Our mission is to empower biotech and pharmaceutical companies to discover and develop more effective drugs faster, utilizing the power of Large Language Models (LLMs) specifically trained on biological languages.
Where is Converge Bio based?
Converge Bio is based in Tel Aviv, Israel, Israel.
When was Converge Bio founded?
Converge Bio was founded in 2020.
How much has Converge Bio raised?
Converge Bio has raised $0 in their Series A round.